Immediate Impact
67 standout
Citing Papers
Advances in diagnosis and treatment of bladder cancer
2024 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Works of C. Suárez Rodríguez being referenced
Cabozantinib in combination with atezolizumab in urothelial carcinoma previously treated with platinum-containing chemotherapy: Results from cohort 2 of the COSMIC-021 study.
2020
Abstract CT154: Optimization of the dose and schedule of an HDM2 inhibitor NVP-HDM201 in a first-in-human Phase I study using a mechanism-based PK/PD model
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| C. Suárez Rodríguez | 258 | 134 | 117 | 150 | 29 | 309 | |
| Niels Viggo Jensen | 230 | 185 | 95 | 117 | 28 | 363 | |
| Annalisa Guida | 236 | 160 | 69 | 104 | 37 | 311 | |
| B. Escudier | 219 | 94 | 118 | 187 | 41 | 322 | |
| Konstantin Penkov | 212 | 194 | 85 | 133 | 24 | 294 | |
| David Hernández‐Barajas | 155 | 133 | 75 | 135 | 25 | 312 | |
| Annelies Verbiest | 231 | 132 | 112 | 168 | 30 | 369 | |
| Viktoria Stühler | 149 | 94 | 72 | 129 | 34 | 294 | |
| Shivanshu Awasthi | 224 | 137 | 90 | 76 | 27 | 335 | |
| Daniela Cullurà | 200 | 186 | 96 | 74 | 21 | 307 | |
| Jahangeer Malik | 216 | 149 | 72 | 85 | 20 | 257 |
All Works
Loading papers...